Iovance Biotherapeutics, Inc. short interest in 2024
In 2024, Iovance Biotherapeutics, Inc.'s disclosed short interest ran from 16.91% of shares outstanding on 12 Jan 2024 to 20.11% on 31 Dec 2024, a change of +3.20 percentage points. The year's high was 21.91% on 31 Jul 2024 and its low 16.40% on 31 Jan 2024, averaging 19.01% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.52 days on 15 Oct 2024. Full history: Iovance Biotherapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 16.91% (12 Jan 2024)
- End of year
- 20.11% (31 Dec 2024)
- Change
- +3.20 pp
- High
- 21.91% (31 Jul 2024)
- Low
- 16.40% (31 Jan 2024)
- Average
- 19.01%
- Highest days to cover
- 15.52 (15 Oct 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 16.91% | 5.89 | |
| 31 Jan 2024 | 16.40% | 7.22 | |
| 15 Feb 2024 | 16.79% | 7.73 | |
| 29 Feb 2024 | 18.25% | 1.74 | results (8-K), 10-K filed, results (8-K) |
| 15 Mar 2024 | 18.53% | 5.04 | |
| 28 Mar 2024 | 18.12% | 8.66 | |
| 15 Apr 2024 | 19.14% | 10.71 | |
| 30 Apr 2024 | 19.56% | 13.43 | |
| 15 May 2024 | 18.30% | 7.69 | 10-Q filed, results (8-K) |
| 31 May 2024 | 17.86% | 8.96 | |
| 14 Jun 2024 | 19.52% | 6.84 | |
| 28 Jun 2024 | 20.16% | 6.68 | |
| 15 Jul 2024 | 21.06% | 9.34 | |
| 31 Jul 2024 | 21.91% | 10.26 | |
| 15 Aug 2024 | 19.55% | 6.62 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 19.01% | 10.14 | |
| 13 Sep 2024 | 19.87% | 9.14 | |
| 30 Sep 2024 | 19.75% | 13.33 | |
| 15 Oct 2024 | 19.88% | 15.52 | |
| 31 Oct 2024 | 19.68% | 11.53 | |
| 15 Nov 2024 | 17.71% | 5.27 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 18.67% | 7.54 | |
| 13 Dec 2024 | 19.47% | 13.13 | |
| 31 Dec 2024 | 20.11% | 8.62 |
See also: Iovance Biotherapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.